Giora Weisz, Philippe Généreux u. a.: Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. In: The Lancet, 387, 2016, S. 136, doi:10.1016/S0140-6736(15)00459-6.
DA Morrow, BM Scirica, E Karwatowska-Prokopczuk, SA Murphy, A Budaj, S Varshavsky, AA Wolff, A Skene, CH McCabe, E Braunwald: Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. PMID 17456819.
R. Jones: Ranolazine (Roche Bioscience). In: IDrugs, 1999, 2, S. 1353–1362. PMID 16113967.